Abstract
Clinical ThyroidologyVol. 33, No. 6 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:8 Jun 2021https://doi.org/10.1089/ct.2021;33.252-253AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail DEAR COLLEAGUES,Welcome to another issue of Clinical Thyroidology. This issue contains yet another exciting look at the latest research on a variety of clinical thyroid topics. We begin the issue with a review by Drs. Sofie Bliddal, Marianne Klose, and Ulla Feldt-Rasmussen summarizing an Italian study of patients with COVID-19 infection evaluated by various thyroid parameters during intensive care hospitalization. Dr. Soumya Thumma and Spyridoula Maraka examine a study assessing the safety of routine iodine supplementation in women with Hashimoto's thyroiditis.On the topic of Graves’ disease, Dr. Benjamin Gigliotti reviews a large Japanese study of patients with Graves’ disease analyzing the predictive factors for achieving remission. On a related note, Drs. Anand Gandhi and Ricardo Correa summarize a study assessing risk factor for the development of thyroid eye disease in those with Graves’ hyperthyroidism. And Drs. Jennifer Clark and Marius Stan share their commentary on a study investigating the potentially protective role of statins in those with newly diagnosed thyroid eye disease.Turning to thyroid nodules and thyroid cancer, Dr. Trevor Angell reviews a study examining the thyroid nodule cytology results in which the Afirma molecular tests might be most useful. Drs. Matthew Balcerek and Donald McLeod provide their perspective on an interesting study that asks: What are the competing risks of death in an older individual who is diagnosed with thyroid cancer? For low-risk papillary thyroid cancers, Dr. Jesse Pasternak summarizes a study of U.S. surgeons surveyed on the appropriate extent of thyroid surgery, while Dr. Maria Papaleontiou reviews a study examining the frequency of thyroid hormone supplementation after thyroid lobectomy. Finally, Dr. Brian Kim provides his expert commentary on a study examining the promise of liquid-based biopsies assessing the molecular signatures in anaplastic thyroid cancers.As always, thank you to all our readers who are connecting with us through our social media platforms. I invite everyone to join the conversations regarding the content covered in each month's issue and other related topics:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgAlso, remember that most of the material covered in Clinical Thyroidology is also translated into shorter lay summaries in our sister journal, Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), that is edited by Dr. Alan Farwell and his team each month. The summaries in CTFP may be of use to patients and the public who are interested in reading more about recently published studies in the clinical thyroid literature.I hope that each issue provides helpful reviews, commentaries, editorials, and perspectives regarding how best to treat patients with thyroid disease. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at clinicalthyroidology@thyroid.org.Warmest regards,Angela M. Leung, MD, MSc Editor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 33Issue 6Jun 2021 InformationCopyright 2021 American Thyroid Association, Inc.To cite this article:Clinical Thyroidology.Jun 2021.252-253.http://doi.org/10.1089/ct.2021;33.252-253Published in Volume: 33 Issue 6: June 8, 2021PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.